[1]Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics,2002[J].CA Cancer J Clin, 2005, 55(2):74-108[2]Siegel RL, Miller KD, Jemal A.Cancer statistics,2015[J].CA Cancer J Clin, 2015, 65(1):5-29[3]Chen W, Zheng R, Baade PD, et al.Cancer statistics in China,2015[J].CA Cancer J Clin, 2016, 66(2):115-132[4]Chen HM, Yu YN, Wang JL, et al.Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma[J].Am J Clin Nutr, 2013, 97(5):1044-1052[5]Geng J, Fan H, Tang X, et al.Diversified pattern of the human colorectal cancer microbiome[J].Gut Pathog, 2013, 5(1):2-[6]Shen XJ, Rawls JF, Randall T, et al.Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas[J].Gut Microbes, 2010, 1(3):138-147[7]Sobhani I, Tap J, Roudot-Thoraval F, et al.Microbial dysbiosis in colorectal cancer (CRC) patients[J].PLoS One, 2011, 6(1):e16393-[8]Wang T, Cai G, Qiu Y, et al.Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers[J].ISME J, 2012, 6(2):320-329[9]Ahn J, Segers S, Hayes RB.Periodontal disease,Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality[J].Carcinogenesis, 2012, 33(5):1055-1058[10]Momen-Heravi F, BabicA, Tworoger SS, et al.Periodontal disease,tooth loss and colorectal cancer risk: Results from the Nurses’ Health Study[J].Int.J Cancer, 2017, 140(3):646-652[11]Mary KB.Evidence accumulates indicating periodontal disease as a risk factor for colorectal cancer or lymphoma[J].CACancer J Clin, 2017, 63(3):173-174[12]Shu XO, Li H, Yang G, et al.Cohort Profile: The Shanghai Men's Health Study[J].Int J Epidemiol, 2015, 44(3):810-818[13]Zheng W, Chow WH, Yang G, et al.The Shanghai Women' s Health Study: rationale, study design, and baseline characteristics [J]. Am J Epidemiol. 2005, 162(11): 1123-1131.[14]Ren HG, Luu HN, Cai H, et al.Oral health and risk of colorectal cancer:results from three cohort studies and a meta-analysis[J].Ann Oncol, 2016, 27(7):1329-1336[15]Jawad A, Johanna E, Gideon Z, et al.Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc[J].Cell Host Microbe, 2016, 20(2):215-225[16]董艳玲, 杨立娟, 吴金鹏.结肠癌患者口腔具核梭杆菌与结肠癌发生关系的研究[J].癌症进展, 2016, 14(4):387-389[17]Chen W, Liu F, Ling Z, et al.Human intestina lumen and mucosa-associated microbiota in patients with colorectal cancer,[J].PLos One, 2012, 7(6):e39743-[18]McCoy AN, Araujo-Perez F, Azcarate-Peril A, et al.Fusobacterium is associated with colorectal adenomas[J].PLoS One, 2013, 8(1):e53653-[19]Warren RL, Freeman DJ, Pleasance S, et al.Co-occurrence of anaerobic bacteria in colorectal carcinomas[J].Microbiome, 2013, 1(1):16-[20]Kostic AD, Gevers D, Pedamallu CS, et al.Genomic analysis identifies association of Fusobacterium with colorectal carcinoma[J].Genome Res, 2012, 22(2):292-298[21]Flanagan L, Schmid J, Ebert M, et al.Fusobacterium nucleatum associates with stages of colorectal neoplasia development,colorectal cancer and disease outcome[J].Eur J Clin Microbiol Infect Dis, 2014, 33(8):1381-1390[22]Mima K, Nishihara R, Qian ZR, et al.Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis[J].Gut, 2016, 65(12):1973-1980[23]Castellarin M, Warren RL, Freeman JD, et al.Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma[J].Genome Res, 2012, 22(2):299-306[24]Marchesi JR, Dutilh BE, Hall N, et al.Towards the human colorectal cancer microbiome[J].PLoS One, 2011, 6(5):e20447-[25]Tjalsma H, Boleij A, Marchesi JR, et al.A bacterial driver-passenger model for colorectal cancer:beyond the usual suspects[J].Nat Rev Microbiol, 2012, 10(8):575-582[26]Kroon E, Arents NA, Halbertsma FJ.Septic arthritis and osteomyelitis in a 10-year-old boy,caused by Fusobacterium nucleatum,diagnosed with PCR/16S ribosomal bacterial DNA amplification [J]. BMJ Case Rep, 2012, 2012.pii:bcr1220115335.[27]Strauss J, Kaplan GG, Beck PL, et al.Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host[J].Inflamm Bowel Dis, 2011, 17(9):1971-1978[28]Han YW, Ikegami A, Rajanna C, et al.Identification and characterization of a novel adhesin unique to oral fusobaceria[J].J Bacteriol, 2005, 187(15):5330-5340[29]Rubinstein MR, Wang X, Liu X, et al.Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherinβ-catenin signaling via its FadA adhesion[J].Cell Host Microbe, 2013, 14(2):195-206[30]Bryant DM, Stow JL.The ins and outs of E-cadherin trafficking[J].Trends Cell Biol, 2004, 4(8):427-434[31]王倩婷, 吴武超, 吴亚菲, 等.具核梭杆菌黏附素的研究进展[J].中华口腔医学杂志, 2014, 49(12):770-773[32]Lee P, Tan KS.Fusobacterium nucleatum activates the immune response through retinoic acid-inducible gene I[J].J Dent Res, 2014, 93(2):162-168[33]Quah SY, Bergenholtz G, Tan KS.Fusobacterium nucleatum induces cytokine production through Toll-like-receptor-independent mechanism[J].Int Endod J, 2014, 47(6):550-559[34]Park SR, Kim DJ, Han SH, et al.Diverse Toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages[J].Infect Immun, 2014, 82(5):1914-1920[35]Gur C, Ibrahim Y, Isaacson B, et al.Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J].Immunity, 2015, 42(2):344-355[36]Scharlau D, Borowicki A, Habermann N, et al.Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre[J].Mutat Res, 2009, 682(1):39-53[37][37Hofmanova J, Strakova N, Vaculova AH, et al.Interaction of dietary fatty acids with tumor necrosis factor family cytokines during colon inflammation and cancer [J]. Mediators Inflamm, 2014, 2014: 848632.[38]Louis P, Hold GL, Flint HJ.The gut microbiota,bacterial metabolites and colorectal cancer[J].Nat Rev Microbiol, 2014, 12(10):661-672[39]殷薛飞, 刘晓慧, 申华莉, 等.具核梭杆菌具核亚种蛋白质组及其在癌症环境下的差异蛋白质组分析[J].化学学报, 2015, 73(4):337-342 |